Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF…

By Dr. Matthew Watson

WATERTOWN, Mass., May 17, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”) today announced the complete results from Part A of the Phase 1b clinical trial of TX45 in patients with Group 2 Pulmonary Hypertension in Heart Failure with preserved Ejection Fraction (“PH-HFpEF”), which are being presented in a late-breaking, oral session at the European Society of Cardiology (ESC) Heart Failure 2025 Congress being held in Belgrade, Serbia. The results include the full cohort of 19 patients in Part A of the Phase 1b trial of TX45, Tectonic’s lead asset and a long-acting relaxin therapy. Interim data for 16 patients in the Phase 1b trial was previously reported in a press release on January 30, 2025.

Read this article:
Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF...

Related Posts

001 Eton Pharmaceuticals Announces Closing of Public Offering [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
002 Agios Announces Withdrawal of European Marketing Authorization Application for TIBSOVO® as a Treatment for Relapsed or Refractory IDH1-mutant Acute... [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
003 Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
004 Stabilization measures taken [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
005 Coherus BioSciences Announces New Employment Inducement Grants [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
006 Biomerica Reports Fiscal 2021 1st Quarter Financial Results [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
007 German Federal Joint Committee (G-BA) Issues Nationwide Reimbursement Decision for EndoPredict® Breast Cancer Prognostic Test [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
008 Y-mAbs Announces Update on Naxitamab and Omburtamab in Neuroblastoma [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
009 SPACs Show Investors Faster, Simpler Way to Go Public [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
010 Psychedelics Experiencing Renaissance, Offer Tremendous Treatment Potential [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
011 Spero Therapeutics to Present Data for All Pipeline Programs at IDWeek 2020 [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
012 Zogenix Receives Positive CHMP Opinion for FINTEPLA® (Fenfluramine) Oral Solution for the Treatment of Seizures in Patients with Dravet Syndrome [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
013 Beyond Air® Presents Positive New Preclinical Data for the Use of a Single Injection of Gaseous Nitric Oxide as a Novel In situ Cancer Vaccination [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
014 CHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe atopic dermatitis [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
015 Aimmune Receives Positive CHMP Opinion on PALFORZIA® for the Treatment of Patients with Peanut Allergy in Europe [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
016 Novartis receives positive CHMP opinion for Leqvio®* (inclisiran), a potential first-in-class siRNA for the treatment of high cholesterol [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
017 Nephros Announces Pricing of $5 Million Registered Direct Offering of Common Stock [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
018 Theratechnologies Appoints Two New Board Members [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
019 Cantor Fitzgerald and Kristen Kluska to Host Zoom Fireside Chat with Ocugen [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
020 First Patient Dosed in Phase II Trial to Treat Complications in COVID-19 [Last Updated On: October 17th, 2020] [Originally Added On: October 17th, 2020]
021 Sepsis Alliance Elects T2 Biosystems CEO as Advisory Board Member [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
022 Iterum Therapeutics to Present Data from Phase 3 Trials in Uncomplicated and Complicated Urinary Tract Infections at IDWeek 2020 [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
023 UPDATE -- Iterum Therapeutics to Present Data from Phase 3 Trials in Uncomplicated and Complicated Urinary Tract Infections at IDWeek 2020 [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
024 Replimune Appoints Tanya Lewis to the Board of Directors [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
025 ORIC Pharmaceuticals Expands Precision Oncology Pipeline with Exclusive License to Brain Penetrant EGFR/HER2 Exon 20 Inhibitor Program [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
026 Neuronetics to Report Third Quarter 2020 Financial and Operating Results and Host Conference Call [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
027 Berkeley Lights Announces Webcast of Third Quarter Financial Results on November 12, 2020 [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
028 Inventiva receives FDA Fast Track designation in MPS VI for its clinical-stage asset odiparci [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
029 Orion upgrades full-year outlook for 2020 [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
030 Constellation Pharmaceuticals to Host Conference Call to Discuss Third Quarter 2020 Results [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
031 Beyond Air® Presents In Vivo Solid Tumor Data Confirming In Situ Cancer Vaccination with a Single Injection of Gaseous Nitric Oxide at the AACR... [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
032 Pacific Biosciences of California, Inc. Third Quarter 2020 Financial Results Call [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
033 22nd Century Group to Highlight its Reduced Nicotine Technology at The Food and Drug Law Institute’s Tobacco and Nicotine Products Regulation and... [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
034 Rafarma Closes Biocogency Merger [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
035 Renibus Therapeutics Announces Presentations at the American Society of Nephrology Kidney Week 2020 [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
036 Quotient Limited to Report Second Quarter 2021 Financial Results and Host Conference Call [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
037 Marrone Bio Innovations Issues Shareholder Letter and Provides Operational Update [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
038 Fortress Biotech’s Partner Company, Journey Medical Corporation, to be Featured in Webinar Hosted by ROTH Capital Partners [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
039 Cocrystal Pharma Provides Update on Influenza A Program [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
040 Reflect Scientific Awarded Patent for COVID Vaccine Capable- Self Powered, Low Temperature Controlled Bulk Shipping System [Last Updated On: October 19th, 2020] [Originally Added On: October 19th, 2020]
041 Athira Pharma to Host Educational Webinar on the Predictive Nature of P300 to Determine Clinical Benefit of Alzheimer’s Disease Treatments [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
042 Data to Be Presented at IDWeek™ 2020 Demonstrate the Economic and Clinical Burden of Respiratory and Multi-Virus Infections in Allogeneic... [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
043 TG Therapeutics Announces Fast Track Designation Granted by the FDA to Ublituximab in Combination with Umbralisib for the Treatment of Adult Patients... [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
044 BridgeBio Pharma, Inc. and the University of Colorado Anschutz Medical Campus Collaborate to Advance Medicines for Genetically Driven Diseases [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
045 AGTC to Participate in Cantor Fitzgerald Virtual Panel: Key Considerations for Gene Therapy Manufacturing and Platforms [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
046 Salk Institute and BridgeBio Pharma Collaborate to Advance Therapies for Genetically Driven Disease [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
047 Beyond Air® Approved to Initiate Clinical Study at 150 ppm Nitric Oxide with LungFit™ for the Treatment of Acute Viral Pneumonia Including COVID-19 [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
048 CRISPR Therapeutics Reports Positive Top-Line Results from Its Phase 1 CARBON Trial of CTX110™ in Relapsed or Refractory CD19+ B-cell Malignancies [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
049 Applied Therapeutics to Present Data on AT-007 for the Treatment of Galactosemia at the American Society of Human Genetics (ASHG) 2020 Annual Meeting [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
050 ADMA Biologics Announces Presentation on Respiratory Viral Infections and New Data on S. Pneumoniae at IDWeek 2020 [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
051 ProMIS Neurosciences Offers its Perspective on the Likelihood of Regulatory Approval of Aducanumab [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
052 SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
053 MediciNova Appoints Carolyn Beaver to its Board of Directors and as Audit Committee Chair [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
054 Syneos Health® Launches Kinetic™ Omnichannel Capability to Accelerate Modern Customer Engagement [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
055 Interim report for the first nine months of 2020 [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
056 PCI Biotech: Preclinical research collaboration with big pharma ended [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
057 Orion Group Interim Report 1-9/2020 [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
058 Idorsia successfully completes capital increase with gross proceeds of CHF 535.5 million [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
059 MDxHealth Provides Q3-2020 Business Update [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
060 Burning Rock to Present Data on Its Early Detection ELSA-seq at ESMO Asia Virtual Congress 2020 [Last Updated On: October 21st, 2020] [Originally Added On: October 21st, 2020]
061 Nicox Selects Development Candidate in a New Class of NO-mediated Intraocular Pressure (IOP) Lowering Agents [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
062 Bone Therapeutics SA: Transparency notification received from S.R.I.W. SA and Sofipôle SA [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
063 Bone Therapeutics SA: Information on the total number of voting rights and shares [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
064 Genocea to Host Third Quarter 2020 Corporate Update Conference Call & Webcast [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
065 First patient dosed in monalizumab Phase 3 clinical trial triggers $50M payment from AstraZeneca [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
066 KBP Biosciences Announces Data Presentation at the American Society of Nephrology Annual Meeting [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
067 Indus Holdings, Inc. Welcomes Bruce Gates to Board of Directors; Announces Results of Annual Shareholder Meeting [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
068 Coherus BioSciences to Report Third Quarter Financial Results on November 5th [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
069 BioCryst to Report Third Quarter 2020 Financial Results on November 5 [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
070 Theratechnologies to Present at Upcoming Investor Conferences on October 29 and November 10, 2020 [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
071 Bioasis Announces Analyst Coverage Initiated by Zacks Investment Research [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
072 Plus Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
073 Shockwave Medical Announces VIVA20 Investor Update and Conference Call Discussing Third Quarter 2020 Results [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
074 Collegium to Host Conference Call to Discuss Third Quarter 2020 Financial Results and Provide Corporate Update [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
075 X4 Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host a Conference Call and Webcast on November 5, 2020 [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
076 Retrophin Announces Agreement to Acquire Orphan Technologies [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
077 Evelo Biosciences to Report Third Quarter 2020 Financial Results on Thursday, October 29, 2020 [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
078 ONCURIOUS I-O Portfolio Directed at Boosting T Cell Influx and Activity in Solid Tumors Announcing First Preclinical Proof of Concept in Proprietary... [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
079 Onxeo Receives Notice of Intent to Grant a New Patent Enhancing the Protection in Europe of AsiDNA™ Combined with PARP Inhibitors [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]
080 Update on current trading for Q3 2020 and updated full-year outlook for 2020 [Last Updated On: October 23rd, 2020] [Originally Added On: October 23rd, 2020]

categoria

Global News Feed commento

commento

Comments Off | data

data

May 18th, 2025

About... Dr. Matthew Watson

This author published 6272 posts in this site.

Share

Comments are closed.

Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research

Previous post - Next post

Copyright :: 2025